Home>Topics>Stocks>GlaxoSmithKline PLC ADR

GlaxoSmithKline PLC ADR GSK

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. GSK agrees UK deal for meningitis shot after Novartis stand-off

      Headlines

      Sun, 29 Mar 2015

      LONDON, March 29 (Reuters) - GlaxoSmithKline has reached a deal with the British government to supply a new meningitis B vaccine, following a lengthy stand-off over price with the product's previous owner Novartis.

    2. BRIEF- GSK receives approval for Encruse Ellipta in Japan

      Headlines

      Thu, 26 Mar 2015

      * Press release - GSK receives approval for Encruse Ellipta (umeclidinium) in Japan for the treatment of COPD

    3. BRIEF- GSK announces start of phase III programme to evaluate retosiban

      Headlines

      Tue, 17 Mar 2015

      * GSK announces start of phase III programme to evaluate retosiban for spontaneous preterm labour

    4. UPDATE 1-Dementia drug research aided by $100 mln venture capital fund

      Headlines

      Tue, 17 Mar 2015

      * Backers include British govt, GSK , J&J, Pfizer, Lilly, Biogen

    5. Ebola booster vaccine trial to combine GSK , Emergent Bio shots

      Headlines

      Mon, 16 Mar 2015

      LONDON, March 16 (Reuters) - Scientists are to test a new two-shot Ebola vaccine using an experimental shot from Britain's GlaxoSmithKline, which is already in clinical trials in Africa, and a new kind of booster from Emergent BioSolutions .

    6. UPDATE 2- GSK raises $853 mln by halving stake in S.African drugmaker

      Headlines

      Fri, 13 Mar 2015

      * British group retains 6.2 percent stake in Aspen (Updates with actual amount raised following sale)

    7. BRIEF-Aspen says David Redfern to remain director post GSK's stake sale

      Headlines

      Fri, 13 Mar 2015

      * APN - GSK announces completion of the sale of half its stake in Aspen

    8. BRIEF- GSK raises $853 mln via partial sale of Aspen Pharmacare shares

      Headlines

      Fri, 13 Mar 2015

      * GSK completes partial sale of Aspen Pharmacare Holdings Ltd shares - LSE announcement

    9. UPDATE 1- GSK to pocket $890 mln by halving stake in S.African drugmaker

      Headlines

      Thu, 12 Mar 2015

      LONDON, March 12 (Reuters) - GlaxoSmithKline has decided to take profits in Aspen Pharmacare by halving its stake in the South African drugmaker, following a long investment in the firm.

    10. GSK launches $890mln placement in Aspen Pharmacare - source

      Headlines

      Thu, 12 Mar 2015

      LONDON, March 12 (Reuters) - GlaxoSmithKline has launched a $890 million share sale in South African drug company Aspen Pharmacare, a source familiar with the matter said on Thursday.

    « Prev12345Next »
    Content Partners